A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.

Clinical trial NCT06063109 · COMPLETED

Trial details

NCT number: NCT06063109
Sponsor: THPharm Corp.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Diabetes Mellitus, Type 2

Start date: 2023-10-09
Primary completion: 2023-11-09
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.